Abstract | OBJECTIVE: CONCLUSION: In the era of molecular targeted therapy, every radiologist who interprets oncologic studies needs to be aware of the unusual patterns of treatment response and should be able to differentiate pseudoprogression of liver metastases from true progression because this distinction has an important impact on clinical management.
|
Authors | Atul Bhanudas Shinagare, Jyothi P Jagannathan, Katherine M Krajewski, Nikhil H Ramaiya |
Journal | AJR. American journal of roentgenology
(AJR Am J Roentgenol)
Vol. 201
Issue 1
Pg. W15-28
(Jul 2013)
ISSN: 1546-3141 [Electronic] United States |
PMID | 23789688
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Contrast Media
- Diagnostic Imaging
- Humans
- Liver Neoplasms
(drug therapy, secondary)
- Molecular Targeted Therapy
- Neoplasms
(drug therapy, pathology)
- Treatment Outcome
|